A Tablet-based Simple Walking Intervention
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this project is to pilot test the effect of a tablet-based cognitive behavioral intervention (Tab-CBI) application on older adults' a) daily steps, b) fatigue level, c) self-efficacy, and d) quality of life at Week 1 (baseline), Week 4 (intervention completion), Week 6 (booster), Week 8 (follow-up #1), and Week 10 (follow-up #2) in a sample of 24 older adults. The investigators hypothesize that (a) individuals receiving Tab-CBI will have increased daily step counts, decreased fatigue level, greater perception of self-efficacy and quality of life than those receiving current RA fatigue management, and that (b) the effects will be sustained up through 4 weeks of follow-ups after the intervention completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2019
CompletedFirst Submitted
Initial submission to the registry
August 30, 2019
CompletedFirst Posted
Study publicly available on registry
September 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2020
CompletedNovember 4, 2020
November 1, 2020
10 months
August 30, 2019
November 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
daily steps
daily step counts measured by an accelerometer
24 hours
Fatigue severity
self-reported fatigue severity measured by PROMIS Fatigue-8a
past 1 week
perception of self-efficacy
self-reported self-efficacy measured by PROMIS Short Form v1.0 Self-Efficacy for Managing Symptoms-8a
24 hours
perceived quality of life
self-reported perception of quality of life measured by WHOQOL
past 2 weeks
Study Arms (2)
Tab-CBI
EXPERIMENTALThe Tab-CBI group receives a tablet preloaded with the Tab-CBI application and an accelerometer. During the study period, the participants have four weekly educational sessions plus one booster session by the research assistant through a videoconferencing tool. The educational modules were developed based on the principles of cognitive behavioral therapy. The key elements of the modules include activity-pacing, adjustment of goal-setting to the current physical condition, setting priorities and structured planning of a simple walking activity and time off, and cognitive restructuring of activity demands (see attached, outline of education modules).
Usual Care
NO INTERVENTIONThe usual care group receives Arthritis related fatigue management which are currently offered to the participants at the recruitment sites. Participant are also instructed to maintain usual activity during the study period. The control group participants also receive an accelerometer to count steps, but without a tablet.
Interventions
Participants receive a tablet preloaded with Tab-CBI application and an accelerometer.
Eligibility Criteria
You may qualify if:
- age \>=50
- has greater than minimal fatigue scoring ≥17 on the PROMIS Fatigue Short Form v1.0 Fatigue-8a.
- self-reported diagnosis of Arthritis
- having Wi-Fi at home.
You may not qualify if:
- those who are currently engaging in regular exercise
- non-ambulatory or having a condition that would limit the ability to walk (e.g., foot deformity, lower extremity joint surgery in past 6 months, stroke, severe chronic obstructive pulmonary disease, etc.)
- overt delirium, dementia, or any conditions indicating deteriorating cognitive status as determined by the Mini-Cog
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Massachusetts
Amherst, Massachusetts, 01003, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeungok Choi, PhD
University of Massachusetts, Amherst
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
August 30, 2019
First Posted
September 3, 2019
Study Start
May 23, 2019
Primary Completion
March 15, 2020
Study Completion
March 18, 2020
Last Updated
November 4, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share